Markerless motion capture has emerged as a potential substitute for traditional marker-based systems, offering scalable, non-invasive acquisition of human movement. Despite increasing adoption in research and sports applications, its clinical utility for children with complex gait patterns remains an open question. To address this gap, simultaneous marker-based and markerless data were collected in 202 pediatric children (12.1 ± 3.9 years). Marker-based kinematics were processed using the Shriners Children’s Gait Model (SCGM), while markerless outputs were computed using Theia3D with identical Cardan sequences. Agreement between systems was evaluated using statistical parametric mapping (SPM), root-mean-square error (RMSE), and a gait pattern classification based on the plantarflexor–knee extension index. Markerless output systematically underestimated pelvic tilt, hip rotation, and knee rotation and demonstrated reduced between-subject variance in the transverse plane. SPM revealed widespread waveform differences, although most were of negligible effect, especially in the sagittal plane. Mean sagittal-plane RMSEs were < 5° for the knee and ankle and < 8° for the pelvis and hip. Coronal-plane deviations were < 7°, whereas transverse-plane errors exceeded 10°. RMSE increased significantly with body mass index and use of a walker (p < 0.001). Agreement in sagittal-plane gait classification was moderate between systems (κ = 0.60; 67% overall concordance). These results indicate that markerless motion capture is suitable for analyses emphasizing sagittal deviations but remains limited for applications requiring precise axial or frontal-plane estimation. Future work should address algorithmic underestimation of transverse motion and evaluate markerless performance across increasing severity of gait deviation.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of Western Institutional Review Board - Copernicus Group (WCG) gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors